Male and female subjects with CKD stage 5 under peritoneal dialysis
Age ≥18 years
Mental ability to understand the study procedures and provide informed consent
At least 3 months on peritoneal dialysis prior to enrollment
At least 3 daily exchanges
Stable PD prescription for the last 2 months
Subject who is self-treated
You may not be if
Need of cycler (APD)
Known Mechanical problem during the last month (i.e. drainage or fill problems)
Pregnant or breastfeeding women, and women with childbearing potential who is unwilling or unable to use an acceptable method of contraception to avoid pregnancy throughout the entire clinical trial period.
Subjects who are unwilling or unable to comply with study procedures
Known Peritonitis or other catheter related infection during the last 3 months prior to enrollment
Known Congestive Heart Failure stage III-IV
Any history of kidney malignancy
Any planned hospitalization for elective Procedure(s)throughout the duration of participation in the study
Non-elective hospitalization in the last 3 months prior to enrollment
Any other medical or mental condition, that at the investigator's discretion may prevent the subject from participating in the study
Participation in any other clinical study within 4 weeks prior to enrollment
Clareo Health | A Prospective, Open-label, Multi-center Pilot Study to Evaluate the Safety, Feasibility and Usability of the IDA
